ArticleOncotarget2017

Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison.

Sung Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.